Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1410160-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M701TVIL1410160J1), received between Aug 8, 2019 and Jul 7, 2021 — classified as 3 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Insufficient Device Problem Information3
- Patient-Device Incompatibility2
- Device-Device Incompatibility1
- Partial Blockage1
Patient problems
- Failure of Implant1
- No Consequences Or Impact To Patient1
- Occlusion1
- Stenosis1
- Thrombus1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJul 7, 2021Patient-Device Incompatibility; Insufficient Device Problem Information; Patient-Device Incompatibility; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY (5) FIVE YEARS AFTER POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH A TYPE 1B ENDOLEAK. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY IMPLANTING (2) TWO OVATION IX ILIAC LIMB STENT-GRAFTS. THE ENDOLEAK WAS SUCCESSFULLY SEALED AND THE PATIENT WAS REPORTED TO BE DOING WELL.
Patient problems: Failure of Implant
MAUDE report 12129407 ↗InjuryJan 8, 2021Partial Blockage; Patient-Device Incompatibility; Device-Device Incompatibility; Insufficient Device Problem Information; Partial Blockage; Patient-Device Incompatibility; Device-Device Incompatibility; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). DURING THE INITIAL IMPLANT PROCEDURE AND POST POLYMER FILL OF THE AORTIC BODY STENT GRAFT, THE PATIENT EXPERIENCED HYPOTENSION DUE TO A SUSPECTED POLYMER LEAK AND WAS SUCCESSFULLY TREATED FOR AN ANAPHYLACTIC REACTION PER THE DEVICE IFU. REFERENCE MFR. REPORT # 3008011247-2018-00109 FOR THIS PREVIOUS REPORTED EVENT TO THE PATIENT. NOW APPROXIMATELY TWO AND A HALF (2.5) YEARS POST INITIAL PROCEDURE DURING A ROUTINE FOLLOW-UP, A COMPUTED TOMOGRAPHY (CT) SCAN REVEALED THE RIGHT-SIDE LIMB IS SIGNIFICANTLY STENOSED WITH INTRA-GRAFT THROMBUS. NO ENDOLEAK WAS IDENTIFIED AND THE AAA REGRESSED AND APPEARS SEALED. RE-INTERVENTION WAS COMPLETED ON (B)(6) 2020 WITH THE IMPLANT OF TWO (2) OVATION IX ILIAC LIMBS. THE PATIENT IS DOING WELL POST PROCEDURE.
Patient problems: Stenosis; Thrombus
MAUDE report 11143521 ↗InjuryAug 8, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT; INITIAL PROCEDURE INCLUDED COILING WITH COVERING OF THE RIGHT-SIDE HYPOGASTRIC ARTERY DUE TO AN ANEURYSMAL ILIAC AND TORTUOSITY OF BOTH ILIACS. APPROXIMATELY NINE (9) MONTHS POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH A POSSIBLE LIMB FLOW REDUCTION AND HIGH VELOCITY, MONOPHASIC (OCCLUSION) OF THE RIGHT LIMB DETECTED BY ULTRASOUND. HOWEVER, THE EXACT DATE OF EVENT IS UNKNOWN. THE PHYSICIAN WILL CONTINUE TO MONITOR THE PATIENT. AS OF DATE, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED. SUBSEQUENT TO THE INITIAL REPORT, CLINICAL ASSESSMENT DETERMINED THERE WAS NO VISIBLE FLOW REDUCTION OR OCCLUSION OBSERVED ON THE COMPUTERIZED TOMOGRAPHY SCAN FROM (B)(6) 2019; THEREFORE, THERE WAS NO DEVICE MALFUNCTION.
Patient problems: No Consequences Or Impact To Patient; Occlusion
MAUDE report 8876316 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page